Showing results (221-230 of 420) with videos related to
Sort By:
Pageof 42
Journal of Clinical Medicine|January 10, 2026
Value of Stool-Based Colorectal Cancer Screening: Integrating Real-World Adherence, Detection, and Prevention in a Cohort-Based Modeling AnalysisA Mark Fendrick, Derek W Ebner, Michael Dore, et al.Annals of Internal Medicine|February 1, 2003
Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysisJohn M Inadomi, Richard Sampliner, Jesper Lagergren, et al.Journal of Managed Care Pharmacy : JMCP|November 19, 2004
Cost-minimization analysis of once-weekly versus thrice-weekly epoetin alfa for chemotherapy-related anemiaPierre Y Crémieux, John M Fastenau, George Kosicki, et al.Joint Commission Journal on Quality and Safety|September 30, 2003
Differences in the reporting of care-related patient injuries to existing reporting systemsL Keoki Williams, Manel Pladevall, A Mark Fendrick, et al.Archives of Neurology|November 16, 2011
The evaluation of distal symmetric polyneuropathy: a physician survey of clinical practiceBrian C Callaghan, Kevin Kerber, Andrea L Smith, et al.The American Journal of Psychiatry|May 4, 2004
Extent and cost of informal caregiving for older Americans with symptoms of depressionKenneth M Langa, Marcia A Valenstein, A Mark Fendrick, et al.Health Affairs (Project Hope)|January 9, 2018
Medicare Advantage Ratings And Voluntary Disenrollment Among Patients With End-Stage Renal DiseaseQijuan Li, Amal N Trivedi, Omar Galarraga, et al.The New England Journal of Medicine|April 15, 2016
Early Performance of Accountable Care Organizations in MedicareJ Michael McWilliams, Laura A Hatfield, Michael E Chernew, et al.Journal of General Internal Medicine|May 20, 2017
Insurance Transitions and Changes in Physician and Emergency Department Utilization: An Observational StudyMichael L Barnett, Zirui Song, Sherri Rose, et al.Advances in Therapy|January 5, 2023
Continuity of Care Within a Single Patient Support Program for Patients with Rheumatoid Arthritis Prescribed Second or Later Line Advanced TherapyA Mark Fendrick, Philip Mease, Matthew Davis, et al.Pageof 42